Affinity Asset Advisors, LLC

Name: Affinity Asset Advisors, LLC: Form 13F holdings for the quarter ended 2026-06-30
Creator: Listed

An institutional investment manager in NEW YORK, NY. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1773195.

Share this page

Link

Story card, 1080 × 1920

Reported value$2.21bn
Positions113

Holdings: 113 positions

The filing on sec.gov

As filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.

Affinity Asset Advisors, LLC, holdings
Issuer	Class	CUSIP	Reported value$m	Weight	Shares	Put or call	Change on the quarter before
Roivant Sciences Ltd	SHS	G76279101	133	6.0%	3,750,000		Added+950,000
Apogee Therapeutics Inc	COM	03770N101	131	5.9%	987,000		Reduced−297,926
Spyre Therapeutics IncSYRE	COM NEW	00773J202	114	5.1%	1,279,134		Unchanged
Xenon Pharmaceuticals IncXENE	COM	98420N105	96.3	4.4%	1,595,000		Reduced−80,000
Erasca IncERAS	COM	29479A108	96.2	4.3%	5,250,000		Reduced−100,000
Insmed IncINSM	COM PAR $.01	457669307	69.3	3.1%	650,000		Added+170,000
Praxis Precision Medicines IPRAX	COM NEW	74006W207	61.9	2.8%	185,000		Added+15,000
Alkermes plc	SHS	G01767105	58.9	2.7%	1,125,000		Reduced−225,000
Oruka Therapeutics IncORKA	COM	687604108	56.2	2.5%	590,000		Added+90,327
Anaptysbio IncANAB	COM	032724106	55.8	2.5%	826,109		Reduced−113,891
Avalo Therapeutics IncAVTX	COM NEW	05338F306	53.6	2.4%	2,900,000		Added+1,559,160
Cytokinetics IncCYTK	COM NEW	23282W605	46.9	2.1%	550,000		Reduced−150,483
Revolution Medicines IncRVMD	COM	76155X100	46.8	2.1%	250,000		Added+150,000
Abivax SAABVX	SPONSORED ADS	00370M103	44.0	2.0%	330,000		Reduced−75,000
First Tracks BiotherapeuticsTRAX	ORD SHS	337185102	40.9	1.8%	2,032,012		New+2,032,012
Dianthus Therapeutics IncDNTH	COM	252828108	39.0	1.8%	400,000		Added+50,000
Sutro Biopharma IncSTRO	COM SHS	869367201	38.9	1.8%	1,172,487		Added+102,968
Moderna IncMRNA	COM	60770K107	35.0	1.6%	500,000	Put	New+500,000
Nuvalent Inc	COM	670703107	34.0	1.5%	275,000		Reduced−25,000
Trevi Therapeutics IncTRVI	COM	89532M101	33.6	1.5%	1,800,172		Reduced−200,000
Moderna IncMRNA	COM	60770K107	33.3	1.5%	475,000	Call	Reduced−325,000
Ark ETF TR	GENOMIC REV ETF	00214Q302	31.5	1.4%	750,000	Call	New+750,000
Ovid Therapeutics IncOVID	COM	690469101	27.3	1.2%	10,144,562		Reduced−491,756
Lexeo Therapeutics IncLXEO	COM	52886X107	27.0	1.2%	5,807,611		Added+757,400
Celldex Therapeutics Inc NewCLDX	COM NEW	15117B202	26.0	1.2%	700,000		Added+200,000
Belite Bio IncBLTE	SPONSORED ADS	07782B104	25.4	1.1%	165,000		Added+100,000
Enliven Therapeutics IncELVN	COM	29337E102	25.4	1.1%	500,000		Reduced−86,904
Forte Biosciences Inc	COM NEW	34962G208	24.3	1.1%	1,145,391		Added+133,501
ELI Lilly & CoLLY	COM	532457108	24.0	1.1%	20,000	Call	New+20,000
Nurix Therapeutics IncNRIX	COM	67080M103	23.5	1.1%	967,620		Unchanged
Alto Neuroscience IncANRO	COM SHS	02157Q109	22.4	1.0%	850,000		Added+350,000
Madrigal Pharmaceuticals IncMDGL	COM	558868105	21.5	1.0%	40,000		Reduced−15,000
Protagonist Therapeutics IncPTGX	COM	74366E102	21.1	1.0%	172,125		Unchanged
Mineralys Therapeutics IncMLYS	COM	603170101	20.2	0.9%	750,000		Unchanged
Relay Therapeutics IncRLAY	COM	75943R102	19.6	0.9%	1,050,000		Added+650,000
Sagimet Biosciences IncSGMT	COM SER A	786700104	19.3	0.9%	2,497,864		Added+1,629,844
Jade Biosciences IncJBIO	COM NEW	008064206	18.7	0.8%	840,350		Added+200,394
Cogent Biosciences IncCOGT	COM	19240Q201	17.4	0.8%	450,000		Reduced−300,000
Travere Therapeutics IncTVTX	COM	89422G107	17.0	0.8%	300,000		Unchanged
Cullinan Therapeutics IncCGEM	COM	230031106	15.9	0.7%	875,760		Added+94,500
Savara IncSVRA	COM	805111101	15.5	0.7%	2,512,153		Unchanged
Ideaya Biosciences IncIDYA	COM	45166A102	14.9	0.7%	400,000		New+400,000
Perspective Therapeutics IncCATX	COM NEW	46489V302	14.4	0.6%	4,214,582		Added+1,050,000
Odyssey Therapeutics IncODTX	COMMON STOCK	67613T104	14.3	0.6%	766,346		New+766,346
Cogent Biosciences Inc	NOTE 1.625%11/1	19240QAA0	13.7	0.6%	$11,000,000 principal		Added+4,000,000
Omeros CorpOMER	COM	682143102	13.4	0.6%	1,411,300	Put	New+1,411,300
Helix Acquisition Corp III	USD CL A ORD SHS	G4444S107	13.3	0.6%	1,250,000		Unchanged
Equillium IncEQ	COM	29446K106	13.1	0.6%	4,100,000		Added+2,873,690
Alkermes plc	SHS	G01767105	13.1	0.6%	250,000	Call	New+250,000
Establishment Labs Holdings Inc	COM	G31249108	12.7	0.6%	148,013		Added+48,013
Climb Bio IncCLYM	COM	28658R106	12.7	0.6%	972,000		Added+272,000
Teva Pharmaceutical Inds Ltd	SPONSORED ADS	881624209	12.7	0.6%	374,000		Reduced−1,026,000
Veradermics IncMANE	COMMON STOCK	922967104	12.3	0.6%	100,000		Added+30,000
Arrowhead Pharmaceuticals inARWR	COM	04280A100	12.2	0.6%	150,000		Reduced−50,000
Omeros Corp	NOTE 9.500% 6/1	682143AK8	12.2	0.6%	$6,525,000 principal		Unchanged
Taysha Gene Therapies IncTSHA	COM SHS	877619106	11.9	0.5%	1,750,000		Added+750,000
Damora Therapeutics Inc	COM NEW	36322Q206	11.1	0.5%	425,000		Reduced−25,000
Eupraxia Pharmaceuticals IncEPRX	COM	29842P105	10.9	0.5%	1,650,000		Added+60,995
Vera Therapeutics IncVERA	CL A	92337R101	10.7	0.5%	250,000		Unchanged
Proqr Thrapeutics N V	SHS EURO	N71542109	10.3	0.5%	5,543,936		Added+3,089,658
Newamsterdam Pharma Company	ORDINARY SHARES	N62509109	9.3	0.4%	275,000		Unchanged
Korro Bio IncKRRO	COM	500946108	9.3	0.4%	706,904		Unchanged
Uniqure NV	SHS	N90064101	9.2	0.4%	200,000	Call	Reduced−100,000
Anteris Technologies GlobalAVR	COM	03675P102	9.0	0.4%	912,397		Unchanged
Zura Bio Ltd	CLASS A ORD SHS	G9TY5A101	8.6	0.4%	1,464,303		Reduced−1,100,000
Uniqure NV	SHS	N90064101	8.1	0.4%	175,000		New+175,000
Ascendis Pharma A/S	ORD SHS	K08588103	8.0	0.4%	30,000		New+30,000
Ibio IncIBIO	COM NEW	451033708	7.0	0.3%	4,007,881		Added+900,681
Generate Biomedicines IncGENB	COM SHS	370920100	6.7	0.3%	400,000		Added+50,000
Evommune IncEVMN	COM SHS	30054Y107	6.6	0.3%	500,100	Put	New+500,100
Tyra Biosciences IncTYRA	COM	90240B106	6.4	0.3%	200,012		Reduced−57,500
Sol-Gel Technologies Ltd	SHS NEW	M8694L137	6.3	0.3%	84,900		Added+49,900
SAB Biotherapeutics IncSABS	COM NEW	78397T202	5.9	0.3%	1,525,000		Added+950,000
Macrogenics IncMGNX	COM	556099109	5.6	0.3%	1,216,606		Added+716,606
Crispr Therapeutics AG	NAMEN AKT	H17182108	5.5	0.2%	100,000		Reduced−50,000
Newamsterdam Pharma Company	*W EXP 99/99/999	N62509117	5.3	0.2%	245,000		Unchanged
Assembly Biosciences IncASMB	COM NEW	045396207	5.2	0.2%	190,000		New+190,000
Rezolute IncRZLT	COM NEW	76200L309	5.2	0.2%	1,000,000		Reduced−547,641
Precision Biosciences IncDTIL	COM NEW	74019P207	5.1	0.2%	646,576		Added+48,630
Hemab Therapeutics Holdings IncCOAG	COM SHS	423494103	5.1	0.2%	138,030		New+138,030
Viridian Therapeutics IncVRDN	COM	92790C104	4.6	0.2%	250,000		Unchanged
Arrivent Biopharma IncAVBP	COM	04272N102	4.3	0.2%	125,000		Reduced−50,000
Verrica Pharmaceuticals IncVRCA	COM SHS	92511W207	4.3	0.2%	707,338		Unchanged
Compass Pathways plcCMPS	SPONSORED ADS	20451W101	4.3	0.2%	301,183		Reduced−807,300
MBX Biosciences IncMBX	COM	55287L101	4.1	0.2%	75,000		Reduced−75,000
Research Alliance Corp III	ORD SHS CL A	G75226103	4.0	0.2%	370,000		New+370,000
Immunovant IncIMVT	COM	45258J102	3.9	0.2%	100,000		Unchanged
Amanat Acquisition Corp	CL A ORD	G0375M101	3.8	0.2%	375,000		New+375,000
Biohaven Ltd	COM	G1110E107	3.7	0.2%	250,000		New+250,000
Faeth Therapeutics IncFTH	COM NEW	81728A207	3.6	0.2%	144,404		New+144,404
Karyopharm Therapeutics IncKPTI	COM NEW	48576U205	3.1	0.1%	312,500		Reduced−187,500
Alector IncALEC	COM	014442107	3.0	0.1%	1,510,000		Added+1,010,000
Spyglass Pharma IncSGP	COM SHS	85220G109	2.9	0.1%	131,586		Reduced−118,414
Crinetics Pharmaceuticals in	COM	22663K107	2.8	0.1%	75,000		Unchanged
Oaktree Acquisition Corp III	UNIT 10/04/2029	G6717R120	2.8	0.1%	250,000		Unchanged
Celcuity Inc	NOTE 0.250% 8/0	15102KAB6	2.3	0.1%	$2,000,000 principal		New+2,000,000
Jatt II Acquisition Corp	ORD SHS	G50765109	2.3	0.1%	200,000		New+200,000
Neumora Therapeutics Inc.NMRA	COM	640979100	1.8	<0.1%	1,070,651		New+1,070,651
Amylyx Pharmaceuticals IncAMLX	COM	03237H101	1.8	<0.1%	98,999		New+98,999
Adlai Nortye LtdANL	SPONSORED ADS	00704R109	1.8	<0.1%	153,847		Reduced−10,901
Spruce Biosciences IncSPRB	COM NEW	85209E208	1.6	<0.1%	30,000		New+30,000
Summit Therapeutics IncSMMT	COM	86627T108	1.5	<0.1%	100,000	Call	New+100,000
Eikon Therapeutics IncEIKN	COM	282564103	1.3	<0.1%	98,001		New+98,001
Onkure Therapeutics IncOKUR	COM CL A	68277Q105	1.1	<0.1%	240,963		Unchanged
Engene Therapeutics IncENGN	COM	29286X101	1.0	<0.1%	600,000		New+600,000
X4 Pharmaceuticals IncXFOR	COM NEW	98420X202	0.7	<0.1%	145,000		Unchanged
Boundless Bio IncBOLD	COM	10170A100	0.6	<0.1%	250,000		New+250,000
Lenz Therapeutics IncLENZ	COM	52635N103	0.6	<0.1%	100,000		Unchanged
Q32 Bio IncQTTB	COM	746964105	0.4	<0.1%	27,777		Unchanged
Orchestra Biomed Holdings IncOBIO	COM	68572M106	0.1	<0.1%	33,400		Reduced−369,150
Nextcure IncNXTC	COM NEW	65343E207	0.1	<0.1%	41,960		Reduced−199,866
Adagio Med Holdings IncADGM	COM	00534B100	0.1	<0.1%	80,000		Unchanged
Rocket Pharmaceuticals Inc	*W EXP 09/02/202	77313F114	0.0	<0.1%	75,000		Unchanged

Sold out: 18 positions

Held at the end of the quarter before and not reported this quarter.

Affinity Asset Advisors, LLC, positions sold out
Issuer	Class	CUSIP	Weight	Shares	Put or call	Change on the quarter before
Arcellx Inc	COMMON STOCK	03940C100	0.0%	0		Sold out−362,764
Ascendis Pharma A/S	SPONSORED ADR	04351P101	0.0%	0		Sold out−95,000
Bridgebio Pharma IncBBIO	COM	10806X102	0.0%	0		Sold out−150,000
Bristol-Myers Squibb CoBMY	COM	110122108	0.0%	0	Call	Sold out−300,000
Celcuity IncCELC	COM	15102K100	0.0%	0	Call	Sold out−30,000
Celcuity Inc	NOTE 2.750% 8/0	15102KAA8	0.0%	$0 principal		Sold out−3,000,000
Centessa Pharmaceuticals plc	SPONSORED ADS	152309100	0.0%	0		Sold out−1,400,000
CG Oncology IncCGON	COM	156944100	0.0%	0	Call	Sold out−60,000
Corcept Therapeutics IncCORT	COM	218352102	0.0%	0		Sold out−50,000
Dianthus Therapeutics IncDNTH	COM	252828108	0.0%	0	Call	Sold out−50,000
Engene Holdings Inc	COM	29286M105	0.0%	0		Sold out−610,370
Immunitybio IncIBRX	COM	45256X103	0.0%	0	Put	Sold out−1,250,000
Kezar Life Sciences Inc	COM NEW	49372L209	0.0%	0		Sold out−229,076
Novo-Nordisk a SNVO	ADR	670100205	0.0%	0	Call	Sold out−175,000
Revolution Medicines IncRVMD	COM	76155X100	0.0%	0	Put	Sold out−100,000
State STR SPDR S&P 500 ETF TSPY	TR UNIT	78462F103	0.0%	0	Put	Sold out−200,000
Terns Pharmaceuticals Inc	COM	880881107	0.0%	0		Sold out−562,631
Wave Life Sciences Ltd	SHS	Y95308105	0.0%	0		Sold out−1,401,727

Source: SEC EDGAR, Form 13F-HR, accession 0001011438-26-000516 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.